ZNF582 and neoplasm: In the multivariate analysis, where patient age at surgery, tumor grade, disease stage, and ER/PR status were adjusted, ZNF582-AS1 expression remained significantly associated with relapse (HR = 0.42, 95%CI: 0.21–0.61, p = 0.012), but not with death (p = 0.373).